Market revenue in 2022 | USD 42.6 million |
Market revenue in 2030 | USD 67.8 million |
Growth rate | 6% (CAGR from 2022 to 2030) |
Largest segment | Bone access devices |
Fastest growing segment | Balloon Catheters |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Balloon Catheters, Bone Access Devices, Cement Application Products, Instruments |
Key market players worldwide | Stryker Corp, Medtronic PLC, Smith & Nephew PLC, MicroPort Scientific Corp, Johnson & Johnson, Halma PLC, CareFusion, Merit Medical Systems Inc, iMedicom, Seawon Meditech, Joline, G21, Joimax |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to kyphoplasty market will help companies and investors design strategic landscapes.
Bone access devices was the largest segment with a revenue share of 42.25% in 2022. Horizon Databook has segmented the Germany kyphoplasty market based on balloon catheters, bone access devices, cement application products, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
Germany’s kyphoplasty market held significant market share. This can be attributed to increasing medical insurance coverage and reimbursement for patients. In July 2018, eviCore healthcare, which manages over 100 million lives, published a positive recommendation for exclusive use of the triangular iFuse Implant and that took effect in October 2018.
Apart from this, in January 2018, Blue Cross Blue Shield Association, community-based and locally operated Blue Cross, and a national federation of 36 independent & Blue Shield companies that provided healthcare coverage for more than 106 million members, published their triangle recommendation for spine and MIS SI joint fusion.
In May 2018, AIM Specialty Health, owned by Anthem, issued its exclusive iFuse policy, which became effective in July 2018 in Germany. Introduction of new-generation spine surgeons is a major key driver contributing to market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany kyphoplasty market , including forecasts for subscribers. This country databook contains high-level insights into Germany kyphoplasty market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account